Ultragenyx Pharma (RARE) PT Raised to $39 at Canaccord

September 18, 2026 6:38 AM

Canaccord analyst Whitney Ijem raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $39.00 (from $37.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found